Cited by 169Long-Term Effects of COVID-19Infectious Encephalopathies and EncephalitisCOVID-19 Clinical Research Studies

The DOI matches its Crossref record; 15 of the 19 references it cites were found in a registry or an index.

Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline

Open access

Pinna, Pranusha, Grewal, Parneet, Hall, Julianne P., Tavarez, Tachira, Dafer, Rima M., Garg, Rajeev, Osteraas, Nicholas D., Pellack, Danielle R., Asthana, Anjali, Fegan, Kelsey, Patel, Vikram, Conners, James J., John, Sayona, Silva, Ivan Da·2020·Journal of the Neurological Sciences

DOI 10.1016/j.jns.2020.116969PMC PMC7832569

Open this paper in CoChat — free account Open PDF

Abstract

Objective To report neurological manifestations seen in patients hospitalized with Coronavirus disease 2019 (COVID-19) from a large academic medical center in Chicago, Illinois. Methods We retrospectively reviewed data records of 50 patients with COVID-19 who were evaluated by the neurology services from March 1, 2020 - April 30, 2020. Patients were categorized into 2 groups based on timing of developing neurological manifestations: the "Neuro first" group had neurological manifestations upon initial assessment, and the "COVID first" group developed neurological symptoms greater than 24 h after hospitalization. The demographics, comorbidities, disease severity and neurological symptoms and diagnoses of both groups were analyzed. Statistical analysis was performed to compare the two groups. Results A total of 50 patients (48% African American and 24% Latino) were included in the analysis. Most common neurological manifestations observed were encephalopathy (n = 30), cerebrovascular disease (n = 20), cognitive impairment (n = 13), seizures (n = 13), hypoxic brain injury (n = 7), dysgeusia (n = 5), and extraocular movement abnormalities (n = 5). The "COVID-19 first" group had more evidence of physiologic disturbances on arrival with a more severe/critical disease course (83.3% vs 53.8%, p 0.025). Conclusion Neurologic manifestations of COVID-19 are highly variable and can occur prior to the diagnosis of or as a complication of the viral infection. Despite similar baseline comorbidities and demographics, the COVID-19 patients who developed neurologic symptoms later in hospitalization had more severe disease courses. Differently from previous studies, we noted a high percentage of African American and Latino individuals in both groups.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jns.2020.116969

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101623 · Cited by 2,542
Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms
Baig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00122 · Cited by 2,207
COVID-19 and African Americans
Yancy, C. W. (2020) · JAMA · doi:10.1001/jama.2020.6548 · Cited by 1,932
COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis
Li, L., Huang, T., Wang, Y., Wang, Z., Liang, Y., Huang, T., Zhang, H., Sun, W., & Wang, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25757 · Cited by 1,531

Show all 19 references

Sorted by citations

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA.
Taquet, M., Luciano, S., Geddes, J. R., & Harrison, P. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30462-4 · Cited by 1,484
Long covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655
Stroke in COVID-19: A systematic review and meta-analysis
Nannoni, S., de Groot, R., Bell, S., & Markus, H. S. (2020) · International Journal of Stroke · doi:10.1177/1747493020972922 · Cited by 611
Lifting the mask on neurological manifestations of COVID-19
Pezzini, A., & Padovani, A. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0398-3 · Cited by 447
Morphological, cellular and molecular basis of brain infection in COVID-19 patients
Crunfli, F., Carregari, V. C., Veras, F. P., Vendramini, P. H., Valença, A. G. F., Antunes, A. S. L. M., Brandão-Teles, C., da Silva Zuccoli, G., Reis-de-Oliveira, G., Silva-Costa, L. C., et al. (2020) · doi:10.1101/2020.10.09.20207464 · Cited by 331
Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences
von Bartheld, C. S., Hagen, M. M., & Butowt, R. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00460 · Cited by 294
Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic
Sharifian, M., Huot, P., Osherov, M., Wen, D., Saveriano, A., Giacomini, P. S., Antel, J. P., & Mowla, A. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117085 · Cited by 230
Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions
Favas, T. T., Dev, P., Chaurasia, R. N., Chakravarty, K., Mishra, R., Joshi, D., Mishra, V. N., Kumar, A., Singh, V. K., Pandey, M., et al. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04801-y · Cited by 218
Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia
Alonso-Lana, S., Marquié, M., Ruiz, A., & Boada, M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.588872 · Cited by 211
The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning
de Erausquin, G. A., Snyder, H. M., Carrillo, M. C., Hosseini, A. A., Brugha, T. S., & Seshadri, S. S. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12255 · Cited by 204
Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study
Pérez‐González, A., Araújo-Ameijeiras, A., Fernández‐Villar, A., Casal, M. C., Poveda, E., Cabrera, J. J., del Campo, V., de Araujo, B. G., Gómez, C., Leiro‐Fernández, V., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07414-x · Cited by 138
Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis
Mutiawati, E., Fahriani, M., Mamada, S. S., Fajar, J. K., Frediansyah, A., Maliga, H. A., Ilmawan, M., Emran, T. B., Ophinni, Y., Ichsan, I., et al. (2021) · F1000Research · doi:10.12688/f1000research.28393.1 · Cited by 127
Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings
Guerrero, J. I., Barragán, L. A., Martínez, J. D., Montoya, J. P., Peña, A., Sobrino, F., Tovar-Spinoza, Z. S., & Ghotme, K. A. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06185-6 · Cited by 112
Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review
Alnefeesi, Y., Siegel, A. N., Lui, L. M. W., Teopiz, K. M., Ho, R., Lee, Y. L., Nasri, F., Gill, H., Lin, K., Cao, B., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.621773 · Cited by 112
A Case of COVID-19-Induced Vestibular Neuritis
Malayala, S. V., & Raza, A. (2020) · Cureus · doi:10.7759/cureus.8918 · Cited by 103
COVID‐19 and ischemic stroke
Sagris, D., Papanikolaou, A., Kvernland, A., Korompoki, E., Frontera, J. A., Troxel, A. B., Gavriatopoulou, M., Milionis, H. J., Lip, G. Y. H., Michel, P., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15008 · Cited by 106
Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up
Nersesjan, V., Amiri, M., Lebech, A., Roed, C., Mens, H., Russell, L., Fonsmark, L., Berntsen, M., Sigurðsson, S. Þ., Carlsen, J. F., et al. (2021) · Journal of Neurology · doi:10.1007/s00415-020-10380-x · Cited by 95
Seizure in patients with COVID-19
Emami, A., Fadakar, N., Akbari, A., Lotfi, M., Farazdaghi, M., Javanmardi, F., Rezaei, T., & Asadi‐Pooya, A. A. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04731-9 · Cited by 90
COVID-19 and the central nervous system
Alomari, S. O., Abou-Mrad, Z., & Bydon, A. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106116 · Cited by 90
Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care
Toniolo, S., the Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel, Scarioni, M., Lorenzo, F. D., Hort, J., Georges, J., Tomić, S., Nobili, F. M., & Frederiksen, K. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210335 · Cited by 86
Cognitive Impairment in Non-critical, Mild-to-Moderate COVID-19 Survivors
Henneghan, A. M., Lewis, K., Gill, E. R., & Kesler, S. R. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.770459 · Cited by 87
A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19
Hawkins, M., Sockalingam, S., Bonato, S., Rajaratnam, T., Ravindran, M., Gosse, P. J., & Sheehan, K. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110350 · Cited by 79
COVID-19 associated cranial nerve neuropathy: A systematic review
Finsterer, J., Scorza, F. A., Scorza, C. A., & FIORINI, A. C. (2021) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2021.6341 · Cited by 80
COVID-19, de novo seizures, and epilepsy: a systematic review
Asadi‐Pooya, A. A., Simani, L., Shahisavandi, M., & Barzegar, Z. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04932-2 · Cited by 80
COVID‐19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases
Iyer, M., Jayaramayya, K., Devi, S. M., & Vellingiri, B. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29937 · Cited by 77
Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients
Cheruiyot, I., Sehmi, P. K., Ominde, B. S., Karau, P. B., Mislani, M., Ngure, B., Olabu, B. O., & Ogeng’o, J. A. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04870-z · Cited by 76
Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species
Arnsten, A. F. T. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2020.107327 · Cited by 75
“The anti-inflammatory effects of guanfacine may also be useful for treating the long-term neural consequences of COVID-19, where a subset of patients report sustained mental problems (Heneka, Golenbock, Latz, Morgan, & Brown, 2020; Pinna et al., 2020).”
Oral Symptoms Associated with COVID-19 and Their Pathogenic Mechanisms: A Literature Review
Tsuchiya, H. (2021) · Dentistry Journal · doi:10.3390/dj9030032 · Cited by 76
COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management
Fraiman, P. H. A., Godeiro-Junior, C. D. O., Moro, E., Cavallieri, F., & Zedde, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.574694 · Cited by 78
Headache associated with COVID‐19: Epidemiology, characteristics, pathophysiology, and management
Rocha‐Filho, P. A. S. (2022) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14319 · Cited by 74
Neuro-ophthalmologic complications of coronavirus disease 2019 (COVID-19)
Gold, D. M., & Galetta, S. L. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135531 · Cited by 69
The Sexual Long COVID (SLC): Erectile Dysfunction as a Biomarker of Systemic Complications for COVID-19 Long Haulers
Sansone, A., Mollaioli, D., Limoncin, E., Ciocca, G., Bắc, N. H., Thắng, N. C., Hou, G., Yuan, J., Zitzmann, M., Giraldi, A. G. E., et al. (2021) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2021.11.001 · Cited by 72
RETRACTED AND REPLACED: Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis
Hannum, M. E., Koch, R. J., Ramirez, V. A., Marks, S. S., Toskala, A. K., Herriman, R. D., Lin, C., Joseph, P. V., & Reed, D. R. (2022) · Chemical Senses · doi:10.1093/chemse/bjac001 · Cited by 67
Retracted
Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis - a systematic review and meta-analysis
Syahrul, S., Maliga, H. A., Ilmawan, M., Fahriani, M., Mamada, S. S., Fajar, J. K., Frediansyah, A., Syahrul, F. N., Imran, I., Harris, S., et al. (2021) · F1000Research · doi:10.12688/f1000research.42308.1 · Cited by 56
Post-covid syndrome: a review of pathophysiology, neuropsychiatric manifestations and treatment perspectives
Khasanova, D. R., Zhitkova, Y. V., & Рушановна, В. Г. (2021) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2021-3-93-98 · Cited by 60
Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study
Rocha‐Filho, P. A. S., Albuquerque, P. M., Carvalho, L. C. L. S., Gama, M. D. P., & Magalhães, J. E. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01367-8 · Cited by 63
Olfactory Dysfunction, Headache, and Mental Clouding in Adults with Long-COVID-19: What Is the Link between Cognition and Olfaction? A Cross-Sectional Study
Stadio, A. D., Brenner, M. J., Luca, P. D., Albanese, M., D’Ascanio, L., Ralli, M., Roccamatisi, D., Cingolani, C., Vitelli, F., Camaioni, A., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12020154 · Cited by 73
Clinical and Imaging Characteristics in Patients with SARS-CoV-2 Infection and Acute Intracranial Hemorrhage
Nawabi, J., Morotti, A., Wildgruber, M., Boulouis, G., Krähling, H., Schlunk, F., Can, E., Kniep, H. C., Thomalla, G., Psychogios, M., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082543 · Cited by 52
SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viabilityPreprint
Crunfli, F., Carregari, V. C., Veras, F. P., Vendramini, P. H., Valença, A. G. F., Antunes, A. S. L. M., Brandão‐Teles, C., Zuccoli, G. S., Reis‐de‐Oliveira, G., Silva-Costa, L. C., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-104944/v1 · Cited by 53
Potential for Cognitive Communication Impairment in COVID-19 Survivors: A Call to Action for Speech-Language Pathologists
Ramage, A. E. (2020) · American Journal of Speech-Language Pathology · doi:10.1044/2020_ajslp-20-00147 · Cited by 73
Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19
Bhandari, R., Khanna, G., Kaushik, D., & Kuhad, A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02344-7 · Cited by 46
Extrapulmonary onset manifestations of COVID-19
Finsterer, J., Scorza, F. A., Scorza, C. A., & FIORINI, A. C. (2021) · Clinics · doi:10.6061/clinics/2021/e2900 · Cited by 43
Neurological toll of COVID-19
Bhola, S., Trisal, J., Thakur, V., Kaur, P., Kulshrestha, S., Bhatia, S. K., & Kumar, P. (2022) · Neurological Sciences · doi:10.1007/s10072-022-05875-6 · Cited by 42
Pathophysiological Mechanisms and Neurological Manifestations in COVID-19
Gupta, R., Garg, A., Sapra, H., Gurnani, A., Kakkar, G., Khatib, K. I., Kulkarni, A. P., Bansal, A. R., Dash, S. K., Khan, A., et al. (2020) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23592 · Cited by 31
Neurological manifestation in COVID-19 disease with neuroimaging studies.
Ghaderi, S., Olfati, M., Ghaderi, M., Hadizadeh, H., Yazdanpanah, G., Khodadadi, Z., Karami, A., Papi, Z., Abdi, N., Jalali, S. S. S., et al. (2023) · PubMed Central · Cited by 28
Case of COVID-19-induced vestibular neuritis in a child
Giannantonio, S., Scorpecci, A., Montemurri, B., & Marsella, P. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-242978 · Cited by 29
Neurological Manifestations in Patients Hospitalized with COVID-19: A Retrospective Analysis from a Large Cohort in Northern Italy
Travi, G., Rossotti, R., Merli, M., D’Amico, F., Chiappetta, S., Giussani, G., Panariello, A., Corradin, M., Vecchi, M., Raimondi, A., et al. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15159 · Cited by 26
Post-COVID-19 Benign Paroxysmal Positional Vertigo
Maslovara, S., & Košec, A. (2021) · Case Reports in Medicine · doi:10.1155/2021/9967555 · Cited by 27
The wide spectrum of COVID-19 neuropsychiatric complications within a multidisciplinary centre
Delorme, C., Houot, M., Rosso, C., Carvalho, S., Nédelec, T., Maatoug, R., Pitron, V., Gassama, S., Sambin, S., Bombois, S., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab135 · Cited by 29
Chronic neuropsychiatric sequelae of SARS‐CoV‐2: Protocol and methods from the Alzheimer's Association Global Consortium
de Erausquin, G. A., Snyder, H. M., Brugha, T. S., Seshadri, S. S., Carrillo, M. C., Sagar, R., Huang, Y., Newton, C. R. J. C., Tartaglia, M. C., Teunissen, C. E., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12348 · Cited by 27
Self-citation
Neurological complications after COVID-19: A narrative review
Molaverdi, G., Kamal, Z., Safavi, M., Shafiee, A., Mozhgani, S., Ghobadi, M. Z., & Goudarzvand, M. (2023) · eNeurologicalSci · doi:10.1016/j.ensci.2023.100485 · Cited by 27
Facial Nerve Paralysis and COVID ‐19: A Systematic Review
Namavarian, A., Eid, A. A., Ziai, H., Cheng, E. Y., & Enepekides, D. (2022) · The Laryngoscope · doi:10.1002/lary.30333 · Cited by 26
Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis
Hannum, M. E., Koch, R. J., Ramirez, V. A., Marks, S. S., Toskala, A. K., Herriman, R. D., Lin, C., Joseph, P. V., & Reed, D. R. (2023) · Chemical Senses · doi:10.1093/chemse/bjad043 · Cited by 27
Gustatory dysfunction in COVID-19 patients: a rapid systematic review on 27,687 cases
Cirillo, N., Bizzoca, M. E., Muzio, E. L., Cazzolla, A. P., & Muzio, L. L. (2021) · Acta Odontologica Scandinavica · doi:10.1080/00016357.2020.1869828 · Cited by 25
Eye Movement Alterations in Post-COVID-19 Condition: A Proof-of-Concept Study
García, C., Costa, M. C., Saltaren, R. J., Santos, C. P., Gómez‐Andrés, D., & Benito‐León, J. (2022) · Sensors · doi:10.3390/s22041481 · Cited by 30
Neurological manifestations as prognostic factors in COVID-19: a retrospective cohort study
Rocha‐Filho, P. A. S., Magalhães, J. E., Silva, D. F., Soares, M. C., Buarque, L. M. D. A., Gama, M. D. P., & de Oliveira, F. A. A. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-021-01851-7 · Cited by 23
Persisting Shadows: Unraveling the Impact of Long COVID-19 on Respiratory, Cardiovascular, and Nervous Systems
Sideratou, C.-M., & Papaneophytou, C. P. (2023) · Infectious Disease Reports · doi:10.3390/idr15060072 · Cited by 23
SARS-CoV-2 Emergency and Long-Term Cognitive Impairment in Older People
Rizzo, M. R., & Paolisso, G. (2021) · Aging and Disease · doi:10.14336/ad.2021.0109 · Cited by 19
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review
Mirmosayyeb, O., Ghaffary, E. M., Vaheb, S., Pourkazemi, R., & Shaygannejad, V. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.11.004 · Cited by 21
Neuroprognostication of Consciousness Recovery in a Patient with COVID-19 Related Encephalitis: Preliminary Findings from a Multimodal Approach
Sangaré, A., Dong, A., Denis-Valente, M., Pyatigorskaya, N., Cao, A., Altmayer, V., Zyss, J., Lambrecq, V., Roux, D., Morlon, Q., et al. (2020) · Brain Sciences · doi:10.3390/brainsci10110845 · Cited by 19
Cognitive impairment in COVID-19 survivors
Оstroumova, Т. М., Chernousov, P. A., & Kuznetsov, I. V. (2021) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2021-1-126-130 · Cited by 21
Unravelling the connection between COVID-19 and Alzheimer’s disease: a comprehensive review
Shajahan, S. R., Kumar, S., & Ramli, M. D. C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1274452 · Cited by 23
Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences
Khaljiri, H. J., Jamalkhah, M., Harandi, A. A., Pakdaman, H., Moradi, M., & Mowla, A. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00389-z · Cited by 21
Regional and Chronological Variation of Chemosensory Dysfunction in COVID-19: a Meta-Analysis
Kim, J., Han, S. C., Jo, H. D., Cho, S., & Kim, J. Y. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e40 · Cited by 22
Cognitive Deficits in the Acute Phase of COVID-19: A Review and Meta-Analysis
de Alcântara, I. J., Nuber‐Champier, A., Voruz, P., Cionca, A., Assal, F., & Péron, J. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030762 · Cited by 17
Clinical significance of angiotensin-converting enzyme 2 receptors for severe acute respiratory syndrome coronavirus 2 (COVID-19) on peripheral small-fiber sensory neurons is unknown today
Oaklander, A. L. (2020) · Pain · doi:10.1097/j.pain.0000000000002050 · Cited by 16
The Philippine COVID-19 Outcomes: a Retrospective study Of Neurological manifestations and Associated symptoms (The Philippine CORONA study): a protocol study
Espiritu, A. I., Sy, M. C. C., Anlacan, V. M. M., & Jamora, R. D. G. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040944 · Cited by 14
Exergames to Prevent the Secondary Functional Deterioration of Older Adults during Hospitalization and Isolation Periods during the COVID-19 Pandemic
Sánchez, A. I. C., López, B. P., Martín‐Conty, J. L., Rodríguez-Hernández, M., Mordillo‐Mateos, L., Schez-Sobrino, S., & Criado‐Álvarez, J. J. (2021) · Sustainability · doi:10.3390/su13147932 · Cited by 16
Hypercoagulability of COVID-19 and Neurological Complications: A Review
MOORE, P. J., Esmail, F., Qin, S., Nand, S., & Berg, S. A. (2021) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2021.106163 · Cited by 17
COVID ‐19 and the risk of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis
Zhang, H., & Zhou, Z. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51688 · Cited by 16
Taste alteration in COVID-19: Significant geographical differences exist in the prevalence of the symptom
Cirillo, N. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.07.002 · Cited by 15
Neuroimaging Patterns in Patients with COVID-19-Associated Neurological Complications
Garg, R. K., Paliwal, V. K., Malhotra, H. S., & Sharma, P. K. (2021) · Neurology India · doi:10.4103/0028-3886.314531 · Cited by 14
Self-citation
Radiological Manifestation of Neurological Complications in the Course of SARS-CoV-2 Infection
Sklinda, K., Dorobek, M., Wasilewski, P. G., Dreżewski, K., Dębicka, M., Walecki, J. M., & Mruk, B. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.711026 · Cited by 14
Neurological involvement in the respiratory manifestations of COVID-19 patients
Tan, B., Liu, J., Gui, Y., Wu, S., Suo, J., & Li, Y. (2021) · Aging · doi:10.18632/aging.202665 · Cited by 15
Incidence of Newly-Diagnosed Dementia After COVID-19 Infection versus Acute Upper Respiratory Infection: A Retrospective Cohort Study
Gollop, C., Zingel, R., Jacob, L., Smith, L., Koyanagi, A., & Kostev, K. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221271 · Cited by 13
SARS-CoV-2 infection and seizures: the perfect storm
Tsai, C., Wilson, S. E., & Rubiños, C. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2104115 · Cited by 12
Extended Neuralgic Amyotrophy Syndrome in a Confirmed COVID-19 Patient After Intensive Care Unit and Inpatient Rehabilitation Stay
Alvarez, A., Amirianfar, E., Mason, M. C., Huang, L., Jose, J., & Tiu, T. (2021) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001795 · Cited by 12
Neurological Presentations in Patients with COVID-19 in Cytokine Storm
Gürsoy, G. T., Yüksel, H., ŞİMŞEK, İ. M., Oral, S., KÜÇÜKDAĞLI, F. E., Karaman, A., Akıncı, E., Baştuğ, A., Güner, R., & Bektaş, H. (2021) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2021.247 · Cited by 11
Evaluation and Treatment of Seizures and Epilepsy During the COVID-19 Pandemic
Pellinen, J., & Holmes, M. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01174-x · Cited by 11
SARS-CoV2 Nsp3 protein triggers cell death and exacerbates amyloid β42-mediated neurodegeneration
Singh, A. P., Chimata, A. V., Deshpande, P., Bajpai, S., Sangeeth, A., Rajput, M., & Singh, A. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382989 · Cited by 9
Neurologic Manifestations of COVID 19 in Children
Gürkaş, E., Dünya, B., Köken, Ö. Y., Demirdağ, T. B., Yilmaz, D., Özyürek, H., & Kurt, A. N. Ç. (2021) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_225_21 · Cited by 9
COVID-19-Induced Seizures: A Meta-Analysis of Case Series and Retrospective Cohorts
Hussaini, H., Rogers, S., Kataria, S., Uddin, K., Mohamed, K. H., Mohamed, A. S., Tariq, F., Ahmad, S., Awais, A., Ahmed, Z., et al. (2022) · Cureus · doi:10.7759/cureus.28633 · Cited by 9
Cognitive impairment in COVID-19: associations, pathogenesis and treatment questions
Golovacheva, V. A., Tabeeva, G. R., & Kuznetsov, I. V. (2021) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2021-2-123-129 · Cited by 9
Long COVID in Hospitalized and Non-Hospitalized Patients in a Large Cohort in Northwest Spain, A Prospective Cohort StudyPreprint
Pérez‐González, A., Araújo, A., Fernández‐Villar, A., Casal, M. C., & Poveda, E. (2021) · Research Square · doi:10.21203/rs.3.rs-796403/v1 · Cited by 9
Impact of COVID-19 on Neuropsychiatric Disorders
Zia, N., Ravanfar, P., Allahdadian, S., & Ghasemi, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175213 · Cited by 8
Cognitive performance of post-covid patients in mild, moderate, and severe clinical situations
Serafim, A. D. P., Saffi, F., Soares, A. R. A., Morita, A. M., Assed, M. M., de Toledo, S., Rocca, C. C. D. A., & Durães, R. S. S. (2024) · BMC Psychology · doi:10.1186/s40359-024-01740-7 · Cited by 12
Postacute Sequelae of COVID-19 and Adverse Psychiatric Outcomes: Protocol for an Etiology and Risk Systematic Review
Effiong, A. (2022) · JMIRx Med · doi:10.2196/43880 · Cited by 8
Epidemiology, pathogenesis, and management of Coronavirus disease 2019-associated stroke
Liu, L., Zhou, C., Wei, H., Wei, H., Zhou, C., Zhou, C., & Ji, X. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1041-7 · Cited by 7
Neurological manifestations in mild and moderate cases of COVID-19
Azim, G. S. A., & Osman, M. A. (2021) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-021-00363-8 · Cited by 8
Seizures in COVID-19: the relationship between biomarkers and prognosis
Boz, P. B., Aslan, K., Şanlı, Z. S., Peköz, M. T., Acar, D., & Bozdemir, H. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-022-02054-4 · Cited by 7
Ophthalmological manifestations of post-COVID-19 syndrome
Yusef, Y. N., Kazaryan, E. E., Анджелова, Д. В., & Vorobyova, M. V. (2021) · Russian Annals of Ophthalmology · doi:10.17116/oftalma2021137052331 · Cited by 7
Association Between Dementia Development and COVID-19 among Individuals Who Tested Negative for COVID-19 in South Korea: A Nationwide Cohort Study
Kim, N., Son, S., Kim, S., Lee, J., Ahn, Y. M., Yon, D. K., & Hahm, B. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175211072387 · Cited by 7
SARS-CoV-2 infection and cognition in community-dwelling and nursing home residents in southern Switzerland
Rizzi, G., Pacifico, D., Sabatini, S., Annoni, A. M., Mele, F., Jovic, S., Piccoli, L., Corna, L., Amati, R., Pertoldi, W., et al. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100701 · Cited by 6
Clinical Characteristics of COVID-19 Infection in the Pediatric Age Group
Gümüş, H., Özcan, Y., Kazanasmaz, H., Demir, A., & Güzelçiçek, A. (2021) · Electronic Journal of General Medicine · doi:10.29333/ejgm/11019 · Cited by 6
Stridor Due to Cranial Nerve X Palsy Progressing to Polyneuropathy in a Teenager With COVID-19
Dean, A. L., Said, A., Marri, K., & Chelius, D. C. (2021) · PEDIATRICS · doi:10.1542/peds.2021-051534 · Cited by 6
Infezioni in Medicina
Menezes, R. G., Alabduladhem, T. O., Siddiqi, A. K., Maniya, M. T., Dahlawi, A. M. A., Almulhim, M., Almulhim, H. W., Saeed, Y. A. A., Alotaibi, M. S., Alarifi, S. H. S., et al. (2023) · Infezioni in Medicina · doi:10.53854/liim-3102-2 · Cited by 6
Multinévrite oculaire dans le cadre d’une infection COVID-19
Raharimanantsoa, O. L., Razakarivony, F. A., Andriamiadanalisoa, A. O., Rajaona, R. A., Rakotoarisoa, R., Randrianarimanana, S. E. R., & Raobela, L. (2020) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2020.08.001 · Cited by 6
Registro argentino de manifestaciones neurológicas por coronavirus-19 (COVID-19)
Alessandro, L., Appiani, F., Bendersky, M., Guerrero, B. B., Bruera, G., Cairola, P., Calandri, I. L., Oliver, J. M. C., Clément, M. E., Egidio, M. D., et al. (2021) · Neurología Argentina · doi:10.1016/j.neuarg.2021.04.001 · Cited by 6
Clinical Spectrum and Neuroimagistic Features in Hospitalized Patients with Neurological Disorders and Concomitant Coronavirus-19 Infection
Gogu, A. E., Motoc, A. G. M., Stroe, A. Z., Axelerad, A. D., Axelerad, D. D., Pârv, F., Munteanu, G., Dan, F., & Jianu, D. C. (2021) · Brain Sciences · doi:10.3390/brainsci11091138 · Cited by 6
COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?
Onaolapo, A. Y., & Onaolapo, O. J. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666211222162811 · Cited by 6

Authors: Pinna, P., Grewal, P., Hall, J. P., Tavarez, T., Dafer, R. M., Garg, R., Osteraas, N. D., Pellack, D. R., Asthana, A., Fegan, K., Patel, V., Conners, J. J., John, S., & Silva, I. D.
Affiliations: Rush University Medical Center (US)
Corresponding author: Pinna, Pranusha
ORCID: Pinna, Pranusha
Grewal, Parneet
Hall, Julianne P.
Tavarez, Tachira
Dafer, Rima M.
Garg, Rajeev
Osteraas, Nicholas D.
Pellack, Danielle R.
Patel, Vikram
John, Sayona
Venue: Journal of the Neurological Sciences
Publisher: Elsevier BV
Published: 2020-08
Volume: 415
Pages: 116969
ISSN: 0022-510X (ISSN-L)
DOI: 10.1016/j.jns.2020.116969
PMC: PMC7832569
OpenAlex: W3033833391
Cited by: 169
References: 19
Citations by year: 2026: 2 · 2025: 3 · 2024: 9 · 2023: 21 · 2022: 45 · 2021: 61 · 2020: 28
FWCI: 16.78
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Journal of the Neurological Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords: COVID-19 pandemic, neurological symptoms, encephalopathy, cerebrovascular disease, cognitive impairment, seizures, hypoxic brain injury, dysgeusia, disease severity, racial disparities, African American patients, Hispanic patients
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Chicago, Female, Humans, Male, Middle Aged, Nervous System Diseases, Pneumonia, Viral, Retrospective Studies, Time Factors, Comorbidity, Coronavirus Infections, Pandemics, Tertiary Care Centers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks